Sage Therapeutics Announces Resignation Of Kimi Iguchi From Her Position As CFO And Treasurer Of The Co And From Any And All Other Positions She Holds As An Officer Or Employee Of The Company Or An Officer, Employee Or Director Of Any Of Its Subsidiaries
Sage Therapeutics Announces Resignation Of Kimi Iguchi From Her Position As CFO And Treasurer Of The Co And From Any And All Other Positions She Holds As An Officer Or Employee Of The Company Or An Officer, Employee Or Director Of Any Of Its Subsidiaries
On October 31, 2024 (the "Separation Date"), Kimi Iguchi and Sage Therapeutics, Inc. (the "Company") entered into a separation agreement (the "Iguchi Separation Agreement") providing for the resignation of Ms. Iguchi from her positions as the Chief Financial Officer and Treasurer of the Company and from any and all other positions she holds as an officer or employee of the Company or an officer, employee or director of any of its subsidiaries. As previously announced, Ms. Iguchi's departure from the Company was part of the October 2024 reorganization of the Company's business operations and reduction in the Company's workforce (the "Reorganization"). The Iguchi Separation Agreement also includes a release of claims by Ms. Iguchi and non-solicitation, non-disclosure and non-disparagement obligations following the Separation Date.
2024年10月31日（"分離日期"），井口君美與Sage Therapeutics, Inc.（"公司"）簽署了一份分離協議（"井口分離協議"），規定井口女士辭去公司首席財務官和財務主管職務以及辭去任何其他在公司或其子公司中擔任的職務的協議。正如先前宣佈的那樣，井口女士離開公司是公司2024年10月業務重組和裁員計劃的一部分（"重組"）。井口分離協議還包括釋放井口女士的索賠以及於分離日期後遵守的非招攬、非披露和非貶低義務。
譯文內容由第三人軟體翻譯。
